GMP Native™: A New Category of Manufacturing Software

There is a conversation happening in supplement, food, and cosmetics manufacturing that the software industry has mostly missed. It is not about features. It is not about integrations or dashboards or AI chatbots. It is about something more fundamental: whether the software you use to run your facility was designed with regulatory compliance as its operating model, or whether compliance was added later as a layer on top of something built for a different purpose entirely.

This distinction matters more than most manufacturers realize, and it is the reason we built BatchBuddy the way we did.

The Problem with "Compliance Features"

For the last two decades, the standard approach to manufacturing software has followed a predictable pattern. A company builds a platform to solve an operational problem: inventory management, production scheduling, order tracking. The platform gains traction. Customers in regulated industries start asking for compliance functionality. The company adds an audit log module. Then an electronic signature add-on. Then a document control section.

The result is a system where compliance exists in pockets. The audit log captures some events but not others. The electronic signature workflow applies to documents but not to batch record entries. The CAPA module tracks corrective actions but does not connect to the inventory lot that triggered the deviation. Each module was built by a different team, at a different time, with a different understanding of what FDA oversight actually requires.

I spent years working in facilities that ran on these systems. I watched quality managers spend the first three hours of every FDA inspection explaining why the audit trail for a given batch record lived in four different places, two of which required separate logins. I watched manufacturers fail 483 observations not because they were doing anything wrong operationally, but because their software made it structurally impossible to produce a coherent compliance record.

The problem was not the people. The problem was the architecture.

What GMP Native™ Means

GMP Native™ is a term we coined to describe a different design philosophy. It means that the regulatory framework, specifically 21 CFR Part 11, Part 111, MoCRA, and FSMA, is not a feature set bolted onto the platform. It is the operating model the platform was built around from day one.

In a GMP Native™ system, regulated records are protected by cryptographic integrity at multiple layers. Electronic signatures use HMAC-SHA256 hashing so that any tampering is mathematically detectable. The audit trail itself is hash-chained: every entry contains a cryptographic link to the previous entry, so that deleting or altering a historical record breaks the chain and the tampering becomes visible. Recall reports are signed with versioned HMAC attestations that bind the report to its underlying trace data. These are not application settings. They are mathematical guarantees.

In a GMP Native™ system, the audit trail is not a separate module that runs alongside your operations. It is a centralized, fail-closed service: the regulated action and its audit entry are committed in a single database transaction, so if the audit write fails, the action itself rolls back. A batch cannot be completed, a deviation cannot be closed, a QC release cannot be signed without the corresponding audit record being persisted in the same atomic operation. The audit trail is not a report you run after the fact. It is a structural property of every regulated workflow in the system.

In a GMP Native™ system, role-based access control is not a permission matrix you configure in an admin panel. It is enforced at every layer of the application: route, service, and database. A quality reviewer cannot inadvertently approve their own deviation. An operator cannot access formulation records outside their assigned production run. A read-only auditor account cannot trigger a write operation regardless of how the request is constructed. These are not settings. They are architectural constraints.

In a GMP Native™ system, the electronic batch record is not a document attached to a production record. It is the production record. Every ingredient lot verified, every yield measurement recorded, every step signed by a qualified operator, every deviation captured with its root cause and resolution: these are first-class objects in the data model, connected to each other through auditable relationships, not assembled from fields in separate modules at report time.

Why This Has Not Existed Until Now

The honest answer is that building software this way is harder and slower than building operational software and adding compliance afterward.

Cryptographic signing requires careful key management, validation documentation, and a signing infrastructure that has to be right the first time. There is no "patch the signing logic" later. If you get it wrong and records are signed incorrectly, those records may not be defensible in an inspection. The validation evidence has to exist before you ship to a regulated customer, not as a roadmap item.

Role enforcement at the infrastructure level means you cannot take shortcuts during development. Every route has to be decorated. Every service call has to check authorization. Every database query has to scope to the authenticated user's organization. This slows down feature development in the short term. It is the only approach that produces a system where access control actually works under adversarial conditions.

A data model where batch records are first-class objects, with ingredients, lots, yield measurements, deviations, and signatures all connected through foreign keys and enforced relationships, is a fundamentally different architecture than a document management system with an audit log. Building it correctly requires understanding what an FDA investigator actually looks at during a records inspection, not just what the regulation says in text.

Most software companies do not have that knowledge. Most manufacturing software companies hire compliance consultants to write the marketing copy and hope the modules are close enough. The ones who have been closest to the problem, the legacy ERP vendors and the pharmaceutical software companies, built their systems in the 1990s and early 2000s, when cloud architecture, modern programming frameworks, and cryptographic primitives at the application layer were not the options they are today.

The window to build a GMP Native™ platform for the supplement, food, and cosmetics market using modern infrastructure opened in the last several years. We walked through it.

The Category, Not Just the Product

I want to be clear about something: we are not simply claiming that BatchBuddy is a better compliance product than the alternatives. We are arguing that GMP Native™ is a distinct product category, and that the distinction matters for how manufacturers evaluate their options.

When you evaluate a system as a "manufacturing platform with compliance features," the evaluation criteria are operational: How fast can I enter a batch record? Does it integrate with my ERP? How much does the inventory module cost? Compliance is a checklist item, usually near the bottom.

When you evaluate a system as a GMP Native™ Operating System, the evaluation criteria change. The first questions become: Can I verify a signed record independently of your platform? What happens to my audit trail if I stop paying for your software? Has your validation package been reviewed by a third-party IQ/OQ specialist? What is your documented approach to 21 CFR Part 11 Section 11.10? These are the questions that matter when an FDA investigator shows up.

Most manufacturers have never been asked these questions by their software vendors. Most software vendors have never been asked these questions by their customers. The result is a market full of systems that look like compliance tools from the outside and fall apart under inspection.

We are trying to change that by naming the category, defining what it means, and building to the standard we are claiming.

What GMP Native™ Looks Like in Practice

For a contract manufacturer running dietary supplements under 21 CFR Part 111, a GMP Native™ system means the following:

Incoming material verification is not a checkbox. It is a structured lot receipt workflow that requires identity verification against the ingredient master, COA potency review with documented acceptance criteria, and operator sign-off with a credential-based electronic signature. Lots can be quarantined on receipt, with release requiring a documented reason and operator attribution, and the system supports two-person sign-off for regulated quality decisions. Every document, from the COA to the label photo, is captured and exportable as an FDA Audit Package.

Batch record execution is not a form you fill out after the fact. It is a guided workflow where each step captures real-time data: measurements, lot numbers consumed, input and output masses. Each entry is timestamped and operator-attributed. Critical batch parameters are locked by ORM-level validators once execution begins, so they cannot be quietly changed mid-run. Deviations from specification trigger formal investigation workflows with root cause analysis, corrective action plans, and multi-phase sign-off. Electronic signatures on batch records use HMAC-SHA256 hashing, and the template instructions are snapshotted at execution time so that later template edits cannot alter the historical record.

Yield management is not a spreadsheet calculation you do after the batch closes. It is a real-time comparison between theoretical yield and actual yield, with automatic flagging of out-of-specification variances, root cause attribution, and trend analysis across production runs. The system tells you when your yield variance pattern suggests a raw material potency drift before it becomes a batch failure.

Recall readiness is not something you test once a year in a mock exercise using your best records. It is a structural property of the data model. Every finished lot can be traced to every ingredient lot that contributed to it, and every ingredient lot can be traced forward to every finished product and customer shipment it touched, in seconds. The relationships are in the schema, connected through foreign keys from supplier receipt through production to customer delivery. Recall simulation reports are HMAC-signed with versioned attestations that bind the report to its underlying trace data, and finalizing a report requires Part 11 compliant re-authentication.

Supplier qualification is not a folder of vendor documents. It is a living risk profile: approved materials, COA history, incoming test results, deviation incidents, and requalification triggers all connected to the purchasing workflow so that a supplier's qualification status is checked before a purchase order can be issued.

None of these things require add-on modules or consulting engagements to configure. They are how the system works.

The Honest Limitations

GMP Native™ design has tradeoffs.

Because the data model is opinionated about how regulated records are structured, BatchBuddy is not infinitely configurable. You cannot redesign the batch record schema to look like your paper batch records. You can configure fields, add custom attributes, and define your own specifications, but the underlying structure, the one that makes the audit trail coherent and the cryptographic signing reliable, is fixed. Manufacturers who need to replicate an idiosyncratic legacy paper workflow exactly will find that constraint frustrating.

Because role enforcement is architectural rather than configurable, you cannot grant a user permissions that the system considers structurally unsafe. A production operator cannot be given the ability to approve their own batch records, regardless of what your internal SOPs say. If your organization has a reason to need that, BatchBuddy is not the right system.

Because the platform is purpose-built for supplement, food, and cosmetics manufacturing, it does not do things that a general-purpose ERP does. It is not an accounting system. It does not manage payroll. It does not run manufacturing for industries with different regulatory frameworks.

These are real limitations. We are telling you about them because a system designed around compliance has to be honest about what it is and what it is not.

Why the Category Name Matters

Naming a category is not a marketing exercise. It is an act of accountability.

When we say GMP Native™, we are making specific claims: that compliance is architectural, not modular; that audit trails are fail-closed and hash-chained, not bolted on; that signing is cryptographic, not procedural; that access control is enforced at every layer of the stack, not managed through a settings panel. Those claims are verifiable. Any FDA auditor can request our validation package. Any manufacturer can ask us to demonstrate the integrity of their audit chain, walk through the hash verification, and see for themselves that the math holds.

If we cannot back up the category claims, the category means nothing and we deserve to be called out on it. That accountability is the point.

The supplement, food, and cosmetics manufacturing industry has been sold "compliance software" for decades. Most of it has not been. Most of it has been operational software with compliance vocabulary in the marketing materials. The 483 observations keep coming. The warning letters keep coming. The recall failures keep coming, not because manufacturers are careless, but because the systems they trusted to help them were not built to do what they claimed.

GMP Native™ is an attempt to change that. Not by adding better features to the old model, but by building from a different set of first principles.

What We Are Building Toward

BatchBuddy is not finished. No serious platform is.

The areas we are actively building toward include deeper agentic AI: not chatbots that answer questions about GMP, but autonomous agents that monitor your production data continuously, flag anomalies before they become deviations, initiate supplier requalification workflows when incoming test results trend in the wrong direction, and generate audit-ready documentation automatically from the records that already exist in the system.

We are building toward formal third-party validation packages: IQ/OQ documentation that a manufacturer's quality team can use directly for FDA qualification, not as a starting point but as a complete deliverable.

We are building toward open verification: a public endpoint where any signed BatchBuddy record can be verified by any party without requiring a BatchBuddy account, because cryptographic trust should not depend on a vendor relationship.

And we are building toward industry-specific depth in food manufacturing under FSMA and cosmetics manufacturing under MoCRA, two regulatory frameworks that are maturing rapidly and where the same pattern we saw in dietary supplements is playing out: manufacturers operating on general-purpose systems that were not designed for what regulators are now requiring.

The Invitation

If you are a manufacturer operating under FDA, FSMA, or MoCRA oversight, I want to ask you a direct question: When was the last time you looked at your compliance software and asked whether it would hold up if an FDA investigator asked to verify a record independently?

Not whether you could produce the record. Whether the record's integrity could be verified without depending on your vendor's assurances.

If you have never asked that question, or if you asked it and the answer made you uncomfortable, I think it is worth a conversation.

GMP Native™ is not a feature checklist. It is a different way of thinking about what manufacturing software is for. If that resonates with how you think about running your facility, we would like to talk.

Kelly Hackett Co-Founder & CEO, BatchBuddy